Physician profile
Faiz U Khan
NPI 1861698904
$2,848.25
in general payments reported to CMS, 2019-2025
38 companies · $469 in 2025
The $469 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.71 · 2020: $50.83 · 2021: $272 · 2022: $478 · 2023: $715 · 2024: $765 · 2025: $469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,949.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $432.29 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $316.92 | 2021-2025 | |
| Pfizer INC. | $208.47 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $201.83 | 2022-2024 | |
| Glaxosmithkline, LLC. | $158.56 | 2020-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.60 | 2020-2025 | Jardiance, Tradjenta, Stiolto Respimat |
| Boston Scientific Corporation | $145.59 | 2019-2023 | Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $138.62 | 2022-2024 | Airsupra |
| Lilly USA, LLC | $110.38 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Shield Therapeutics INC | $103.63 | 2024 | |
| Vanda Pharmaceuticals INC. | $71.47 | 2025 | Fanapt |
| Phathom Pharmaceuticals, INC. | $69.63 | 2024-2025 | Voquezna |
| Amgen INC. | $57.42 | 2021-2022 | |
| Exact Sciences Corporation | $56.43 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $55.84 | 2021-2023 | Vaxneuvance, Gardasil 9, Vaxelis |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faiz Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.